ACR/ARHP Scientific Meeting 08

Nov 20, 08 NEW STORY 11:39 ET MedPredict's Rheumatology Panel Analyzes Rheumatoid Arthritis, Lupus and Gout Markets and Pipelines Following ACR Conference   Oct 27, 08 08:00 ET Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis